Treating people who start HIV treatment late with a package of low-cost drugs to prevent serious infections saves three lives for every 100 people treated, according to the findings of a trial led by the Medical Research Council (MRC) Clinical Trials Unit at UCL.
Publication date: 20 July 2017
A number of people from the UCL community have been recognised in the Queen’s Birthday Honours list.
Publication date: 23 June 2017
Scientists are closer to understanding the genetic causes of type 2 diabetes by identifying 111 new chromosome locations (‘loci’) on the human genome that indicate susceptibility to the disease, according to a UCL-led study in collaboration with Imperial College London.
Publication date: 4 May 2017
The common antibiotic doxycycline can disrupt the formation of negative associations in the brain, according to new research from UCL and the University of Zurich.
Publication date: 4 April 2017
UCL is involved in the Rosalind Franklin Institute (RFI) – a major new £100 million investment by the government into the development of an innovative multi-disciplinary science and technology research centre.
Publication date: 23 February 2017
Evidence of chronic traumatic encephalopathy (CTE), a potential cause of dementia caused by repeated blows to the head, has been found in the brains of former association football (soccer) players examined at the UCL Queen Square Brain Bank.
Publication date: 15 February 2017
Close friendships facilitate the exchange of information and culture, making social networks more effective for cultural transmission, according to new UCL research that used wireless tracking technology to map social interactions in remote hunter-gatherer populations.
Publication date: 10 February 2017
E-cigarettes are less toxic and safer to use compared to conventional cigarettes, according to research published in Annals of Internal Medicine.
Publication date: 7 February 2017
How the natural defence force within our immune system attacks and destroys harmful invaders such as virus-infected and cancerous cells has been visualised in microscopic detail by scientists from UCL, Birkbeck, University of London, Peter MacCallum Cancer Centre and Monash University, Australia.
Publication date: 7 February 2017
A new non-surgical treatment for low-risk prostate cancer can effectively kill cancer cells while preserving healthy tissue, reports a new UCL-led phase III clinical trial in 413 patients. The trial was funded by STEBA Biotech which holds the commercial license for the treatment.
Publication date: 20 December 2016
People who suffer neglect and abuse in childhood are much more likely to have time off work due to long-term sickness and less likely to own their own homes when they reach middle age than their peers, according to new research undertaken at UCL.
Publication date: 19 December 2016
The number of mothers passing the HIV virus to their babies has fallen to a new record low in the UK and Ireland thanks to the very high take-up of antenatal HIV screening and treatment which reduces virus levels in the pregnant women, according to research led by UCL.
Publication date: 8 December 2016
Significant numbers of patients whose HIV strains developed resistance to older generation drugs are also resistant to modern drugs, finds a new study led by UCL and funded by Wellcome.
Publication date: 1 December 2016
UCL researchers are leading an initiative with The Lancet to address the global health implications of climate change, launching this week in conjunction with today’s 2016 UCL Lancet Lecture.
Publication date: 16 November 2016
Mothers smoking in pregnancy, children skipping breakfast and not having a regular bedtime or sufficient sleep all appear to be important factors in predicting whether a child will become overweight or obese, according to new research led by UCL.
Publication date: 11 November 2016
Walking briskly or cycling for the recommended 150 minutes a week can reduce a person’s risk of developing type 2 diabetes by up to 26%, according to new research by UCL.
Publication date: 18 October 2016
The Jacobs Foundation have awarded Professor Orazio Attanasio, Head of UCL Economics and Research Director at the Institute for Fiscal Studies (IFS), 1 million Swiss francs for his use of economic models and field experiments to assess and shape early child development programs and policies in low income countries.
Publication date: 12 October 2016
A new spin-out company Achilles Therapeutics has been launched to develop immunotherapies for cancer, based on the work of scientists from UCL and its associated hospitals.
Publication date: 5 October 2016
The first scientists have moved into the new £650 million Francis Crick Institute building in London and are starting work in their purpose-built labs. Next to St Pancras station and the British Library, the Crick will be the biggest biomedical research institute under one roof in Europe.
Publication date: 1 September 2016
The greatest threat to sustainable groundwater in the Indo-Gangetic Basin is contamination and not depletion, according to a study co-authored by UCL researchers and published this week in Nature Geoscience.
Publication date: 30 August 2016
Levels of global biodiversity loss may negatively impact on ecosystem function and the sustainability of human societies, according to UCL-led research.
Publication date: 14 July 2016
In the Bonesetter’s Waiting Room: Travels through Indian Medicine, the second book by Dr Aarathi Prasad (UCL Grand Challenges), will be BBC Radio 4’s Book of the Week from 23 May.
Publication date: 15 May 2016
Universities and Science Minister Jo Johnson has sought to reassure researchers that the proposed restrictions preventing the use of government grants to ‘lobby’ government will not apply to funding from the Research Councils, HEFCE or the National Academies.
Publication date: 21 April 2016
A study of 1.3 million people in Sweden found that the risk of being diagnosed with schizophrenia or other psychoses was three times higher in refugees than in the Swedish-born population.
Publication date: 16 March 2016
HIV drug resistance to tenofovir, an antiretroviral drug vital to most
modern HIV treatment and prevention strategies, is surprisingly and worryingly common
according to a large study led by UCL and funded by the Wellcome Trust.
Publication date: 29 January 2016